English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  We describe the prevalence of invasive carbapenem-resistant  Acinetobacter  spp. isolated from 2005 to 2016 in different regions of Switzerland.    Methods  Using the Swiss Antibiotic Resistance Centre (anresis) database that includes data from 70% of all hospitalized patients and one third of all ambulatory practitioners in Switzerland, we analysed the number of carbapenem-susceptible and resistant  Acinetobacter  spp. isolated from blood or cerebrospinal fluid, and further described their temporal and regional fluctuations.    Results  From 2005 to 2016, 58 cases of resistant or intermediate strains to carbapenem were observed among 632 cases of invasive  Acinetobacter . Multivariable analyses indicated that the number of carbapenem-resistant isolates (mean 4.8 ± sd 2.12) and carbapenem resistance rates per region per annum (8.4% ± 13.9%) were low and stable over the studied period. Large fluctuations were observed at the regional level, with e.g. the North East region displaying resistance rates twice as high as that found in other regions.    Conclusion  Despite a relatively stable number of carbapenem-resistant  Acinetobacter  isolates in Switzerland, our results suggest the existence of a diverse pool of  A. baumannii  species in hospital settings, and confirm the implication of carbapenem-resistant  Acinetobacter calcoaceticus - Acinetobacter baumannii  (ACB) complex in the vast majority of clinical infections and nosocomial outbreaks with notable regional fluctuations.    Electronic supplementary material  The online version of this article (10.1186/s12879-018-3061-5) contains supplementary material, which is available to authorized users.

Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland